SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-134774
Filing Date
2024-12-10
Accepted
2024-12-10 08:36:38
Documents
79
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 6-K ipa-20241031.htm   iXBRL 6-K 280295
2 EX-99.1 ipa-ex99_1.htm EX-99.1 659463
3 EX-99.2 ipa-ex99_2.htm   iXBRL EX-99.2 2528215
4 EX-99.3 ipa-ex99_3.htm EX-99.3 24411
5 EX-99.4 ipa-ex99_4.htm EX-99.4 21312
6 GRAPHIC img36100363_0.jpg GRAPHIC 8744
7 GRAPHIC img37023884_0.jpg GRAPHIC 8744
  Complete submission text file 0000950170-24-134774.txt   14432942

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ipa-20241031.xsd EX-101.SCH 1349009
82 EXTRACTED XBRL INSTANCE DOCUMENT ipa-20241031_htm.xml XML 4007135
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 241537223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)